Oct 24, 2024 · NORTH CHICAGO, Ill. and BUDAPEST, Hungary, October 24, 2024 – AbbVie (NYSE: ABBV) and Gedeon Richter Plc. ('Richter') today announced a new discovery, co-development and license agreement to advance novel targets for the potential treatment of neuropsychiatric conditions.